Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	10	15	33	13	5
Market Cap Growth	-39.95%	-33.75%	-54.33%	145.49%	148.64%	14.19%
Enterprise Value	6	11	17	38	24	18
PE Ratio	-	-290.69	3.89	4.08	3.24	3.17
PS Ratio	0.10	0.20	0.27	0.51	0.25	0.11
PB Ratio	0.33	0.52	0.80	2.28	2.19	2.83
P/FCF Ratio	67.66	8.86	4.14	11.86	11.83	-62.23
P/OCF Ratio	13.85	8.02	3.65	10.71	9.94	16.32
EV/Sales Ratio	0.10	0.22	0.30	0.61	0.46	0.36
EV/EBITDA Ratio	11.81	8.63	5.94	5.77	7.62	5.14
EV/EBIT Ratio	-103.71	75.94	8.47	6.58	10.08	6.62
EV/FCF Ratio	67.86	10.07	4.62	13.96	21.37	-206.65
Debt / Equity Ratio	0.11	0.14	0.11	0.42	1.84	6.81
Debt / EBITDA Ratio	3.80	2.05	0.73	0.90	3.53	3.73
Debt / FCF Ratio	21.83	2.39	0.57	2.18	9.90	-149.94
Quick Ratio	0.97	1.21	0.99	0.66	0.46	0.40
Current Ratio	2.63	3.39	3.16	1.95	1.26	1.14
Asset Turnover	2.38	1.99	2.23	2.50	2.30	2.53
Interest Coverage	-88.75	3.00	18.37	22.59	6.01	4.29
Return on Equity (ROE)	-0.61%	-0.18%	20.66%	55.90%	67.71%	89.17%
Return on Assets (ROA)	-0.43%	-0.13%	15.20%	31.50%	17.90%	8.53%
Return on Capital (ROIC)	-0.34%	-0.19%	14.08%	31.45%	18.44%	15.12%
Earnings Yield	-1.84%	-0.34%	25.73%	24.53%	30.87%	31.54%
FCF Yield	1.48%	11.29%	24.16%	8.43%	8.45%	-1.61%
Buyback Yield / Dilution	-2.72%	7.34%	-0.65%	-3.07%	-5.31%	2.41%
Total Shareholder Return	-2.72%	7.34%	-0.65%	-3.07%	-5.31%	2.41%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.